Hart Williford boasts more than 40 years’ experience as an executive in software, revenue management, medical services, sales and digital media, Williford joined Ingenious Med in 2008 and has grown the company twentyfold in terms of revenue, employees and resources. In addition to Ingenious Med, Williford has led four other software solution companies through periods of rapid expansion and profitable growth. His experience extends worldwide as the former leader of Digital Equipment Corp.’s Far East operations, based in Hong Kong. Williford held several senior executive-level positions at leading technology companies including IBM, NCR, AT&T and Kirchman Corp. before joining H.O. Systems as president in 1999. Here he led the company until it was acquired by VeriSign in 2002. While at VeriSign, he continued to oversee the company’s operations as general manager and senior vice president of wireless services. During his five-year tenure, the company was recognized for excellent service, and its revenues grew sevenfold. Williford left VeriSign to serve as president of Morris Technology and simultaneously acted as a board member for Memorial University Medical Center in Savannah, Georgia. He eventually joined Memorial as senior vice president, where he was responsible for its cancer institute, information technology, marketing and strategic planning, foundation and office of sponsored programs, business development and physician relations, and recruitment. Memorial is a two-state academic medical center with US 800 million-dollar-plus in revenue.
Doug Kingsley co-founded North Bridge Growth Equity in 2007 following more than fifteen years at Advent International, where he helped grow the business from $300 million to $10 billion under management, most recently as co-head of US Investments.
Doug started his career in the 1980s at Teradyne, the world’s largest manufacturer of automatic test equipment. He has served on more than twenty-five boards of private and public technology companies, including AspenTech, Proto Labs, SmartPak, and RuffaloCODY. His introduction to private equity came as a consultant to Alcan Aluminum’s venture capital group during the late eighties.
A native New Englander, Doug has studied in Venezuela, Spain, and France. He holds an MBA from Harvard Business School, a BA from Dartmouth College, and a BE from Dartmouth’s Thayer School of Engineering. He is a trustee of St. Sebastian’s School in Needham, MA.
Dr. Liu is the founder of Ingenious Med and creator of the original application. He served 10 years as the company’s CEO and now functions as the executive chairman and CMO. He has previously served as an assistant professor of medicine, medical site director, and director of medical informatics for the Hospital Medicine Division at Emory University in Atlanta. Before his pursuit of medicine, Dr. Liu earned a B.S. in engineering science from the University of Virginia and completed his residency in internal medicine at Washington University, Barnes-Jewish Hospital. Dr. Liu is currently involved in multiple projects involving revenue cycle optimization and government pay-for-performance drives while continuing to practice as a hospitalist physician at Scripps Healthcare in San Diego, CA. He is an active member and senior fellow of the Society of Hospital Medicine and participates in the Society’s Practice Management and Public Policy – Practice Issues committees. Dr. Liu has received recognition as one of the nation’s top hospitalists by the American College of Physicians and was the 2011 recipient of Modern Physician’s Physician Entrepreneur of the Year.
George F. Lynn has more than 30 years of experience as a healthcare executive for provider organizations. For 21 years, he served as president and CEO of AtlantiCare, a clinically integrated health system serving Southeastern New Jersey. In 2009, AtlantiCare received the Malcolm Baldrige National Quality Award.
Mr. Lynn served two terms as chairman of the American Hospital Association. He is active in community service and sits on the Boards of Lourdes Health System and the Cooper Medical School of Rowan University, both located in Camden New Jersey.
He is a member of the board of directors of Valence Health (Chicago, IL) and LHP Hospital Group (Plano, TX). He serves as an advisor to Lillibridge Healthcare (Chicago, IL) and several private equity firms.
David McClellan co-founded Heritage Group, LLC in 1986 and has served as a Managing Director of the firm since 1989. Heritage Group is a privately-held investment and advisory firm focused on early-stage healthcare opportunities. Over the past 30 years, Mr. McClellan has served in numerous executive positions within Heritage Group’s portfolio of companies. In addition to his other activities, since 2002 Mr. McClellan has functioned in a corporate development capacity for several of the companies launched by the firm including Sourcemark, LLC and Theralogix, LLC.
From 1995-1998, Mr. McClellan served as founder and CEO of ProSeed, LLC. The company partnered with hospitals and radiation oncologists and urologists throughout the US to launch prostate brachytherapy centers. The company was acquired by a public company.
From 1992-1995, Mr. McClellan led Corporate Development for Surgical Health Corporation, a company engaged in the development and management of outpatient surgery centers. After acquiring and developing 37 ambulatory surgery centers in the US, the company was acquired by a public company in 1998.
From 1986-1991, Heritage Group developed and managed more than 50 physician/hospital outpatient ventures involving over 5,000 physician investors encompassing a wide array of surgical, diagnostic and therapeutic technologies.
Mr. McClellan holds a BS from the University of Tennessee and a master’s degree in hospital and health administration from the Medical College of Virginia. He began his healthcare career as an associate administrator with Hospital Corporation of America in 1983. Mr. McClellan resides in Nashville with his wife and three children.
Joe Marabito is chief executive officer of Ingenious Med. With more than 25 years of healthcare industry experience, Marabito brings extensive senior leadership, SaaS, operational, consulting, and strategic experience to the company from his various executive roles at health care organizations, leading providers of software solutions, and other services organizations within the health care information technology sector. Prior to joining Ingenious Med, Marabito served as President and CEO of ikaSystems, which offers an enterprise-level, cloud-based platform that administers Commercial, Medicare, Medicaid and Health Exchange lines of business for payers and providers. He also held senior executive positions at Medco, Accenture, NaviNet, and Blue Cross Blue Shield of Missouri.
Marabito earned a Bachelor’s of Science in Mechanical Engineering from Pennsylvania State University and an MBA from Harvard Business School.
Roshen Menon is a general partner at North Bridge Growth Equity and has been with the firm since its inception in 2007. He has been making growth equity investments for over 10 years and focuses on the financial technology, healthcare technology, data analytics, and cloud-based enterprise and infrastructure software sectors.
In addition to Ingenious Med, Roshen has served as an active investor or board member for Clarity Software Solutions, Dyn, Seniorlink, SmartPak, and Valence Health. Before joining North Bridge, Roshen was with a $16 billion private equity firm where he was involved in growth equity investments and management-led buyouts.
Previously, he was a corporate strategy consultant at Deloitte Consulting, advising domestic and international healthcare and technology corporate clients on mergers and acquisitions, growth strategy, operations and new product development. He started his career as an investment banker in the Financial Institutions Group at FleetBoston Financial. Roshen has an AB in psychology and Asian studies from Bowdoin College, where he was a Sarah and James Bowdoin Scholar.
Steele is the former president and chief executive officer of Geisinger Health System. Steele previously served as the dean of the Biological Sciences Division and the Pritzker School of Medicine and as vice president for medical affairs at the University of Chicago, as well as the Richard T. Crane Professor in the Department of Surgery. Before that, he was the William V. McDermott Professor of Surgery at Harvard Medical School, president and chief executive officer of Deaconess Professional Practice Group, Boston, MA, and chairman of the department of surgery at New England Deaconess Hospital (Boston, MA). Widely recognized for his investigations into the treatment of primary and metastatic liver cancer and colorectal cancer surgery, Steele is past chairman of the American Board of Surgery.